{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:51:40Z","timestamp":1781585500247,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shandong Second Medical University","award":["Grant No. 2024FYM142"],"award-info":[{"award-number":["Grant No. 2024FYM142"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04909-6","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:51:33Z","timestamp":1781581893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe Methotrexate toxicity after ectopic pregnancy: a case report managed with continuous renal replacement therapy"],"prefix":"10.1007","volume":"96","author":[{"given":"Yuting","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6973-2792","authenticated-orcid":false,"given":"Aihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-006X","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"4909_CR1","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1007\/s11033-020-05481-9","volume":"47","author":"V Maksimovic","year":"2020","unstructured":"Maksimovic V, Pavlovic-Popovic Z, Vukmirovic S et al (2020) Molecular mechanism of action and pharmacokinetic properties of methotrexate. Mol Biol Rep 47:4699\u20134708. https:\/\/doi.org\/10.1007\/s11033-020-05481-9","journal-title":"Mol Biol Rep"},{"key":"4909_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/hon.2759","volume":"38","author":"I Amitai","year":"2020","unstructured":"Amitai I, Rozovski U, El-Saleh R et al (2020) Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies. Hematol Oncol 38:584\u2013588. https:\/\/doi.org\/10.1002\/hon.2759","journal-title":"Hematol Oncol"},{"key":"4909_CR3","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1200\/jco.2009.25.4540","volume":"28","author":"BC Widemann","year":"2010","unstructured":"Widemann BC, Balis FM, Kim A et al (2010) Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol 28:3979\u20133986. https:\/\/doi.org\/10.1200\/jco.2009.25.4540","journal-title":"J Clin Oncol"},{"key":"4909_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000027851","volume":"100","author":"C Xiao","year":"2021","unstructured":"Xiao C, Shi Q, Cheng Q, Xu J (2021) Non-surgical management of tubal ectopic pregnancy: a systematic review and meta-analysis. Medicine (Baltimore) 100:e27851. https:\/\/doi.org\/10.1097\/md.0000000000027851","journal-title":"Medicine (Baltimore)"},{"key":"4909_CR5","first-page":"1163","volume":"33","author":"YY Yang","year":"2020","unstructured":"Yang YY, Gao L, Ding N et al (2020) How to rescue high-dose methotrexate induced nephrotoxicity and literature review about hemodiafiltration? Pak J Pharm Sci 33:1163\u20131167","journal-title":"Pak J Pharm Sci"},{"key":"4909_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15945","volume":"35","author":"S Ouellette","year":"2022","unstructured":"Ouellette S, Shah R, Razi S et al (2022) Fatal low-dose methotrexate toxicity: a case report and literature review. Dermatol Ther 35:e15945. https:\/\/doi.org\/10.1111\/dth.15945","journal-title":"Dermatol Ther"},{"key":"4909_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bcp.16096","volume":"91","author":"BS Chan","year":"2025","unstructured":"Chan BS, Bosco AA, Buckley NA (2025) Navigating methotrexate toxicity: examining the therapeutic roles of folinic acid and glucarpidase. Br J Clin Pharmacol 91:628\u2013635. https:\/\/doi.org\/10.1111\/bcp.16096","journal-title":"Br J Clin Pharmacol"},{"key":"4909_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4038\/sljog.v46i3.8120","volume":"46","author":"M Sohal","year":"2024","unstructured":"Sohal M, Yadav R, Chopra K (2024) A case of methotrexate toxicity in induced abortion. Sri Lanka J Obstet Gynaecol 46:75\u201378. https:\/\/doi.org\/10.4038\/sljog.v46i3.8120","journal-title":"Sri Lanka J Obstet Gynaecol"},{"key":"4909_CR9","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1002\/onco.13603","volume":"26","author":"WH Alsdorf","year":"2021","unstructured":"Alsdorf WH, Karagiannis P, Langebrake C et al (2021) Standardized supportive care documentation improves safety of high-dose methotrexate treatment. Oncologist 26:e327\u2013e332. https:\/\/doi.org\/10.1002\/onco.13603","journal-title":"Oncologist"},{"key":"4909_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1634\/theoncologist.2017-0243","volume":"23","author":"LB Ramsey","year":"2018","unstructured":"Ramsey LB, Balis FM, O\u2019Brien MM et al (2018) Consensus guideline for use of glucarpidase in patients with high-dose methotrexate induced acute kidney injury and delayed methotrexate clearance. Oncologist 23:52\u201361. https:\/\/doi.org\/10.1634\/theoncologist.2017-0243","journal-title":"Oncologist"},{"key":"4909_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1495705","volume":"12","author":"ACN Tome","year":"2025","unstructured":"Tome ACN, Santos KF, Lima EQ, Ramalho RJ (2025) High-flux hemodialysis as rescue therapy for high-dose methotrexate toxicity: Case series and clinical insights. Front Med (Lausanne) 12:1495705. https:\/\/doi.org\/10.3389\/fmed.2025.1495705","journal-title":"Front Med (Lausanne)"},{"key":"4909_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1424919","volume":"12","author":"T Corbisier","year":"2024","unstructured":"Corbisier T, Von Bueren AO, Breunis WB, Grazioli S (2024) Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: A case report and literature review. Front Pediatr 12:1424919. https:\/\/doi.org\/10.3389\/fped.2024.1424919","journal-title":"Front Pediatr"},{"key":"4909_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2215\/CJN.08030621","volume":"17","author":"M Ghannoum","year":"2022","unstructured":"Ghannoum M, Roberts DM, Goldfarb DS et al (2022) Extracorporeal treatment for methotrexate poisoning: Systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol 17:602\u2013622. https:\/\/doi.org\/10.2215\/CJN.08030621","journal-title":"Clin J Am Soc Nephrol"},{"key":"4909_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/coc.0000000000000932","volume":"45","author":"JH Lewis","year":"2022","unstructured":"Lewis JH, Khaldoyanidi SK, Britten CD et al (2022) Clinical significance of transient asymptomatic elevations in aminotransferase (TAEAT) in oncology. Am J Clin Oncol 45:352\u2013365. https:\/\/doi.org\/10.1097\/coc.0000000000000932","journal-title":"Am J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04909-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:51:42Z","timestamp":1781581902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4909"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04909-6","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}},{"value":"Informed consent was obtained from the patient included in the study. The participant has consented to the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"64"}}